| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Epidemiology Division, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (E-CE, SMZH, and LAP); the Research and Evaluation Division (SMZH and AMRC) and the Health, Nutrition, and Population Programme (SAC), BRAC, Dhaka, Bangladesh; the Department of Nutrition, University of California, Davis (BL); the Division of Nutritional Sciences, Cornell University, Ithaca, NY (J-PH); and the ICDDR,B: Centre for Health and Population Research, Dhaka, Bangladesh (E-CE and LAP).
Background: According to our current understanding, iron absorption with weekly iron supplements is not higher than that with daily supplements (ie, there is no mucosal block). However, community-based trials have repeatedly shown that a weekly regimen is as effective as a daily one. Furthermore, when differences in absorption are found, they are commonly smaller than would be expected on the basis of differences in the amount of iron provided. The possibility of differential compliance between the regimens needs to be evaluated to explain these findings.
Objective: Taking compliance into account, we compared the efficacy and trial effectiveness of weekly and daily iron supplementation during pregnancy.
Design: In Bangladesh, 50 antenatal centers were randomly assigned to prescribe either 2 doses of 60 mg Fe once weekly or 1 dose of 60 mg Fe/d. Compliance was monitored by using a pill bottle equipped with an electronic counting device. Hemoglobin concentrations were measured at baseline and after 4, 8, and 12 wk of supplementation.
Results: There was no differential effect per iron tablet between weekly and daily regimens. A 12-wk daily regimen (68% compliance) produced a small but significantly greater hemoglobin response than did the weekly regimen (104% compliance). The first 20 tablets consumed produced most of the effect; after 40 tablets, there was no further response.
Conclusions: There was no evidence of a mucosal block in the daily regimen. Over 12 wk, 50% of the amount of iron in a daily regimen was sufficient for maximum hemoglobin effect. The weekly regimen provided a large part of this amount, explaining the limited difference in effect. It appears that the current international recommendation for iron supplementation in pregnancy is higher than necessary.
Key Words: Iron supplementation • pregnancy • efficacy • trial effectiveness • weekly dose frequency • Bangladesh
This article has been cited by other articles:
|
|
 |
|
  F. Tofail, L. A. Persson, S. El Arifeen, J. D Hamadani, F. Mehrin, D. Ridout, E.-C. Ekstrom, S. N Huda, and S. M Grantham-McGregor Effects of prenatal food and micronutrient supplementation on infant development: a randomized trial from the Maternal and Infant Nutrition Interventions, Matlab (MINIMat) study Am. J. Clinical Nutrition, March 1, 2008; 87(3): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Baltussen, C. Knai, and M. Sharan Iron Fortification and Iron Supplementation are Cost-Effective Interventions to Reduce Iron Deficiency in Four Subregions of the World J. Nutr., October 1, 2004; 134(10): 2678 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Desai, R. Dhar, D. H. Rosen, S. K. Kariuki, Y. P. Shi, P. A. Kager, and F. O. ter Kuile Daily Iron Supplementation Is More Efficacious than Twice Weekly Iron Supplementation for the Treatment of Childhood Anemia in Western Kenya J. Nutr., May 1, 2004; 134(5): 1167 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Victora, J.-P. Habicht, and J. Bryce Evidence-Based Public Health: Moving Beyond Randomized Trials Am J Public Health, March 1, 2004; 94(3): 400 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Casanueva and F. E. Viteri Iron and Oxidative Stress in Pregnancy J. Nutr., May 1, 2003; 133(5): 1700S - 1708. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
